EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Test-retest reliability, known-groups validity and convergence validity of nocturnal awakening digital endpoints in axial spondyloarthritis

Bogdan Batko, Brygida Kwiatkowska, Susanne Rohrer, Alison Adams, Karen Kapur, Sebin Joy, William Johnston

Digital Biomarkers · 2026-11-10

DOI: 10.1159/dib/acpag006 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background: People with axial spondyloarthritis often experience back pain and stiffness, which worsen with rest and cause nocturnal awakenings. Wrist actigraphy can evaluate these awakenings, but data on the psychometric properties of these digital health technology (DHT) derived measures are limited. These properties are essential for their use in clinical trials. This study aims to evaluate the test-retest reliability, known-groups validity, and convergence validity of DHT-derived measures of nocturnal awakening in people with axial spondyloarthritis, through data collected as part of the INVIGORATE-1 phase 3 clinical trial. Methods: Participants in the trial wore the ActiGraph CentrePoint Insight Watch (CPIW) on their non-dominant wrist for 24 hours a day for up to 28 days during screening window. Three measures of nocturnal awakening were derived: wake after sleep onset (WASO), number of awakenings (NAWAKE) and average length of awakenings (AVGWAKE). Disease activity (ASDAS-CRP) and patient-reported outcomes were also evaluated. Test-retest reliability was assessed using the intra-class correlation coefficient (ICC) and minimal detectable change (MDC) across the two consecutive baseline weeks prior to the end of the screening window. Correlations between nocturnal awakening measures and clinical data were evaluated using the Pearson correlation coefficient. Known-groups validity was assessed by comparing nocturnal awakening between groups with different disease activity levels. Results: Of 526 participants, 447 met the criteria for valid actigraphy data. The three measures of nocturnal awakening showed good test-retest reliability (ICC = 0.75-0.81). MDC values were 36.62 min (WASO), 8.59 awakenings (NAWAKE) and 1.55 min (AVGWAKE). Weak correlations were observed between the nocturnal awakening measures and clinical data, with the strongest correlation between ASDAS-CRP and WASO (r = 0.29). Nocturnal awakening was worse in participants with very high disease activity compared to that in participants with moderate to high disease activity. Conclusions: Actigraphy-based measures of nocturnal awakening have good test-retest reliability and can discriminate between different levels of disease activity. These measures may be sensitive to changes in disease activity, but further research is needed to establish their interventional sensitivity. These findings provide crucial psychometric validation data for DHT-derived measures of nocturnal awakening in the rheumatological disease context.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →